Literature DB >> 15210002

Classification system for the completely dentate patient.

Thomas J McGarry, Arthur Nimmo, James F Skiba, Robert H Ahlstrom, Christopher R Smith, Jack H Koumjian, Gregory N Guichet.   

Abstract

The American College of Prosthodontists (ACP) has developed a classification system designed for use by dental professionals in the diagnosis and treatment of completely dentate patients. This classification is the third in a series and is similar to the Classifications for Complete Edentulism and Partial Edentulism previously developed by the ACP. These guidelines are intended to aid practitioners in the systematic diagnosis of each patient which, in turn, should lead to an appropriate treatment. Four categories of a completely dentate situation are defined (Class I-IV), differentiated by specific diagnostic criteria, with Class I representing an uncomplicated clinical situation and Class IV representing the most complex clinical situation. Potential benefits of the system include (1) improved intraoperator consistency, (2) improved professional communication, (3) insurance reimbursement commensurate with complexity of care, (4) an improved screening tool for dental school admission clinics, (5) standardized criteria for outcomes assessment and research, (6) enhanced diagnostic consistency, and (7) a simplified aid in the decision-making process associated with referral.

Entities:  

Mesh:

Year:  2004        PMID: 15210002     DOI: 10.1111/j.1532-849X.2004.04019.x

Source DB:  PubMed          Journal:  J Prosthodont        ISSN: 1059-941X            Impact factor:   2.752


  1 in total

1.  Eighteen Months Follow-Up with Patient-Centered Outcomes Assessment of Complete Dentures Manufactured Using a Hybrid Nanocomposite and Additive CAD/CAM Protocol.

Authors:  Corina Marilena Cristache; Eugenia Eftimie Totu; Gabriela Iorgulescu; Aida Pantazi; Dorel Dorobantu; Aurelia Cristina Nechifor; Ibrahim Isildak; Mihai Burlibasa; Gheorghe Nechifor; Marius Enachescu
Journal:  J Clin Med       Date:  2020-01-23       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.